Zamerovimab

DB17766InvestigationalProtein Based Therapies

Zamerovimab: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin g1, anti-(rabies lyssavirus spike glycoprotein g) (human-mus musculus clone 1a9 .gamma.1-chain), disulfide with human-mus musculus clone 1a9 .kappa.-chain, dimer · Syn-023 component ctb-011 · Syn023 component ctb-011
Code names
CTB-011

Resolves to

Compound
UNIIDX0L1Z7JO9CAS2419087-87-7
Targets
P08667G

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Zamerovimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In